E Holme

545 total citations
28 papers, 354 citations indexed

About

E Holme is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, E Holme has authored 28 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Rheumatology and 7 papers in Molecular Biology. Recurrent topics in E Holme's work include Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Metabolism and Genetic Disorders (4 papers). E Holme is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Metabolism and Genetic Disorders (4 papers). E Holme collaborates with scholars based in United Kingdom, Sweden and United States. E Holme's co-authors include K Whaley, Jennifer A. Veitch, Asad Zoma, Alistair I. Fyfe, Niklas Darín, Anders Oldfors, M. Tulinius, David A. Hughes, P. Foley and Graham Smith and has published in prestigious journals such as PLoS ONE, Hepatology and European Heart Journal.

In The Last Decade

E Holme

26 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Holme United Kingdom	14	133	96	93	58	54	28	354
Milena Pitashny Israel	9	244 1.8×	56 0.6×	224 2.4×	32 0.6×	34 0.6×	15	514
J Sobajima Japan	7	154 1.2×	63 0.7×	72 0.8×	11 0.2×	48 0.9×	12	346
Strieter Rm United States	7	136 1.0×	80 0.8×	90 1.0×	37 0.6×	7 0.1×	7	402
Mietta Meroni Italy	13	34 0.3×	71 0.7×	94 1.0×	47 0.8×	10 0.2×	36	443
Sándor Dósa United States	14	52 0.4×	102 1.1×	57 0.6×	13 0.2×	10 0.2×	20	419
Cornelia Keller Switzerland	4	124 0.9×	141 1.5×	26 0.3×	23 0.4×	5 0.1×	4	406
Simona Altamura Italy	4	117 0.9×	131 1.4×	97 1.0×	20 0.3×	11 0.2×	4	356
H. Wehinger Germany	12	68 0.5×	96 1.0×	16 0.2×	80 1.4×	25 0.5×	48	379
JI Rotter United States	10	227 1.7×	269 2.8×	57 0.6×	25 0.4×	5 0.1×	21	534
Yasuo Matsuoka Japan	12	35 0.3×	85 0.9×	142 1.5×	60 1.0×	4 0.1×	49	402

Countries citing papers authored by E Holme

Since Specialization

Citations

This map shows the geographic impact of E Holme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Holme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Holme more than expected).

Fields of papers citing papers by E Holme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Holme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Holme. The network helps show where E Holme may publish in the future.

Co-authorship network of co-authors of E Holme

This figure shows the co-authorship network connecting the top 25 collaborators of E Holme. A scholar is included among the top collaborators of E Holme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Holme. E Holme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eggen, Anne Elise, Terje K. Steigen, Tom Wilsgaard, et al.. (2021). Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT). PLoS ONE. 16(3). e0247358–e0247358. 8 indexed citations

Eggen, Anne Elise, Terje K. Steigen, Tom Wilsgaard, et al.. (2020). Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: findings from the Norwegian coronary stent trial (NORSTENT). European Heart Journal. 41(Supplement_2).

Burda, Patricie, Alice Küster, Ola Hjalmarson, et al.. (2015). Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. Journal of Inherited Metabolic Disease. 38(5). 863–872. 29 indexed citations

Darín, Niklas, et al.. (2008). Progressive Encephalopathy and Complex I Deficiency Associated with Mutations in MTND1. Neuropediatrics. 39(1). 24–28. 29 indexed citations

Darín, Niklas, Sophie Lebon, Pierre Rustin, et al.. (2003). Genotypes and Clinical Phenotypes in Children with Cytochrome-cOxidase Deficiency. Neuropediatrics. 34(6). 311–317. 27 indexed citations

Elpeleg, Orly, et al.. (2001). Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I. Human Mutation. 19(1). 80–81. 15 indexed citations

Holme, E, et al.. (2000). ANTIBODY RESPONSE TO STREPTOKINASE. The Journal of Qazvin University of Medical Sciences. 4(15). 8–13.

Squire, Iain, Sue Fletcher, E Holme, et al.. (1999). Humoral and cellular immune responses up to 7·5 years after administration of streptokinase for acute myocardial infarction. European Heart Journal. 20(17). 1245–1252. 21 indexed citations

Brock, Jeremy H., et al.. (1998). Antibodies to lactoferrin. A possible link between cow's milk intolerance and autoimmune disease.. PubMed. 443. 305–11. 4 indexed citations

10.

Smith, Graham, Joyce Davidson, David A. Hughes, E Holme, & T. James Beattie. (1997). Complement activation in Henoch-Schönlein purpura. Pediatric Nephrology. 11(4). 477–480. 23 indexed citations

11.

Burden, A. David, David M. Tillman, P. Foley, & E Holme. (1996). IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. Journal of the American Academy of Dermatology. 35(3). 411–415. 19 indexed citations

12.

Fleming, Colin, E Holme, & R.M. MACKIE. (1996). Systemic complement activation in psoriasis vulgaris. Clinical and Experimental Dermatology. 21(6). 415–418. 8 indexed citations

13.

Birnie, David H., I C McKay, Jennifer A. Veitch, et al.. (1995). Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor. Clinical & Experimental Immunology. 101(3). 393–397. 3 indexed citations

14.

Holme, E, et al.. (1992). The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence. Rheumatology International. 12(5). 187–190. 2 indexed citations

15.

Holme, E, et al.. (1992). Purification and characterization of RHP (factor H) and study of its interactions with the first component of complement. Molecular Immunology. 29(7-8). 957–964. 5 indexed citations

16.

Fagerberg, Björn, Agnethe Berglund, E Holme, Lars Wilhelmsen, & Dag Elmfeldt. (1990). Metabolic effects of controlled‐release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol. Journal of Internal Medicine. 227(1). 37–43. 8 indexed citations

17.

Holme, E, et al.. (1989). Familial properdin deficiency associated with chronic discoid lupus erythematosus.. PubMed. 76(1). 76–81. 17 indexed citations

18.

Holme, E & K Whaley. (1989). Complement and related clinical disorders. Blood Reviews. 3(2). 120–129. 2 indexed citations

19.

Holme, E, et al.. (1988). Quantitation of human C4A and C4B, in serum and plasma by enzyme-linked immunoadsorbent assay. Immunogenetics. 27(4). 295–297. 13 indexed citations

20.

Aitken, R. John, E Holme, D. C. Richardson, & M. J. Hulme. (1982). Properties of intact and univalent (Fab) antibodies raised against isolated, solubilized, mouse zonae pellucidae. Reproduction. 66(1). 327–334. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact